StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

Research analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Down 90.0 %

CALA opened at $0.00 on Thursday. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.